Cataract and IOLs
Conditions
Interventions
Group A: Binocular implantation of AcrySof IQ PanOptix trifocal intraocular lens:observe the incidence rate of posterior capsular opacification and visual outcomes and visual quality 3/6/12/24month
Group B: Binocular implantation of Zeiss LISA Tri 839MP trifocal intraocular lens:observe the incidence rate of posterior capsular opacification and visual outcomes and visual quality 3/6/12/24month a
Sponsors
Chongqing Aier Eye Hospital
Eligibility
Sex/Gender
All
Age
45 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) age-related cataract; 2) corneal astigmatism <=1.0 D; 3) clear cognitive ability; 4) corneal higher-order aberration <0.5 um; kappa<0.5mm; The corneal endothelial cell count was more than 2000 cells/mm2
Exclusion criteria
Exclusion criteria: 1. corneal astigmatism <=1.0 D; corneal diseases, such as corneal degeneration, keratitis, corneal leukoma; 2. optic nerve diseases, such as glaucoma, ischemic optic neuropathy; 3. retinal diseases, such as retinal vascular disease, retinal detachment, macular degeneration; 4. lens subluxation; 5. previous history of trauma of eyes, excimer laser surgery or other intraocular surgery; 6. severe systemic diseases that cannot receive surgery;Patients with serious mental and psychological diseases, intraoperative posterior capsule rupture, intraocular lens suture, intraocular hemorrhage, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the incidence rate of PCO; | — |
Secondary
| Measure | Time frame |
|---|---|
| visual quality; | — |
Countries
China
Contacts
Public ContactMaosheng Chen
Chongqing Aier Eye Hospital
Outcome results
None listed